Cogent Biosciences (COGT) CEO pay: $116.8M actually paid in FY2025
$COGT · Cogent Biosciences, Inc.Data through FY2025 — latest proxy filed 2026-04-23, checked for new filings 2026-08-19. Every number links to its source.
30.1× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2022 | Same, peer group since FY2022 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $27.8M | $116.8M | $40.5M | $413.99 | $120.69 | -$328.9M |
| 2024 | $4.9M | $11.9M | $3.9M | $90.91 | $91.15 | -$255.9M |
| 2023 | $7.9M | -$201,504 | $473,046 | $68.53 | $92.42 | -$192.4M |
| 2022 | $4.4M | $9.8M | $3.2M | $134.73 | $89.09 | -$140.2M |
Frequently asked
How much did the COGT CEO make in 2025?
$116,766,733 in Compensation Actually Paid (CAP) as Cogent Biosciences, Inc.'s CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2026-04-23.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on COGT: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary